Facebook Users

SYNO Synovis Life Technologies, Inc., featured news, full reports, and detailed SYNO.O charts.

Synovis Life Technologies, Inc. (SYNO) Wrap Up:

Synovis Life Technologies, Inc. is a diversified medical device company engaged in developing, manufacturing, marketing and selling products for the surgical and interventional treatment of disease. Our business is conducted in two operating segments, the surgical business and the interventional business, with segmentation based upon the similarities of the underlying business operations, products and markets of each. Our surgical business develops, manufactures, markets and sells implantable biomaterial products, devices for microsurgery and surgical tools, all designed to reduce risk and/or facilitate critical surgeries, leading to better patient outcomes and/or lower costs.  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f01%2f04%2f0000950137-08-000080.html#FIS_BUSINESS"   
www.synovislife.com
235 Employees
Founded in 1985

Synovis Life Technologies Inc. (SYNO:NASDAQ)

LAST $11.89 USD
CHANGE TODAY +0.34 2.94%
VOLUME 81.7K
As of 4:00 PM 11/6/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Synovis Life Technologies Inc. (SYNO)

OPEN
$11.53
PREVIOUS CLOSE
$11.55
DAY HIGH
$12.00
DAY LOW
$11.53
52 WEEK HIGH
07/1/09 - $21.71
52 WEEK LOW
11/21/08 - $11.11
MARKET CAP
137.6M
AVERAGE VOLUME 3 mo
77.1K
DILUTED EPS TTM
$0.04
SHARES OUTSTANDING
11.6M
SYNO Does Not Pay Dividends
P/E TTM
266.2x
K = Thousands  M = Millions  B = Billions

SYNO Details

Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, marketing, and sale of products for the surgical treatment of diseases. Its products include implantable biomaterial products and devices for microsurgery and surgical tools, which are used to reduce risk and/or facilitate critical surgeries. The company’s biomaterial products include Peri-Strips that are biomaterial stapling buttress used as reinforcement at the surgical staple line; Tissue-Guard, which is used to repair and replace damaged tissue in cardiac, vascular, thoracic, and neurologic procedures; and Veritas Collagen Matrix for use in surgery to repair and replace soft tissue. Its devices for microsurgery comprise Microvascular Anastomotic Coupler, which enables microsurgeons in various surgical specialties to perform anastomotic microsurgical procedures; and Neurotube, a device designed to assist in the reconnection of severed nerves. Synovis Life Technologies sells its products through direct sales force and independent distributors primarily in the United States, Europe, Canada, and the Asia Pacific region. The company, formerly known as Bio-Vascular, Inc., was founded in 1985 and is headquartered in St. Paul, Minnesota.

SYNO Top Compensated Officers

Mr. Richard W. Kramp
Chief Executive Officer, President and Direct...
Age: 63
Total Annual Compensation: $348.0K
Mr. Brett A. Reynolds
Chief Financial Officer, Principal Accounting...
Age: 40
Total Annual Compensation: $200.2K
Mr. David A. Buche
Vice President and Chief Operating Officer of...
Age: 47
Total Annual Compensation: $209.1K
Ms. Mary L. Frick MSc
Vice President of Regulatory Affairs, Quality...
Age: 55
Total Annual Compensation: $184.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Synovis Life Technologies Inc. (SYNO)

Synovis Life Technologies Inc. - Conference Presentation Call

To discuss the company's recent performance and market opportunities

Synovis Life Technologies Receives CE Mark Approval for the Use of Veritas(R) Collagen Matrix in Hernia Repair and Breast Reconstruction

Synovis Life Technologies Inc. has received CE Mark approval for its Veritas(R) Collagen Matrix, allowing the company to sell Veritas in the European hernia repair and breast reconstruction markets. Veritas is an extremely conformable and strong biomaterial which acts as a 'scaffold' that allows for rapid repopulation and revascularization by the surrounding host tissue. Veritas is an exceptionally supple and durable product. In addition to providing strength and flexibility, Veritas avoids acute and chronic infections and unwanted chronic inflammation that occurs frequently in response to the use of synthetic patches. The distinct characteristics of Veritas, which include its pericardial substrate and proprietary processing, offer functional and ease of use advantages over other biological patches.

Synovis Life Technologies Inc. - Conference Presentation Call

To discuss the company's recent performance and market opportunities

otc, otcbb, pinksheet, SYNO, ob Synovis Life Technologies Inc.

SYNO Competitors

Company Last Change
Cyberkinetics Neurotechnology Sys Inc $0.0080 USD -0.0005
Neovasc Inc C$0.40 CAD 0.00
Osteotech Inc $3.17 USD -1.03
RTI Biologics Inc $4.09 USD +0.04
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation SYNO Industry Range
Price/Earnings 100.0x
Price/Sales 2.5x
Price/Book 1.6x
Price/Cash Flow 176.4x
TEV/Sales 1.6x

SYNO

 | 

SYNO transactions

Type
Date
Target
Buyback
September 29, 2009
--
Merger/Acquisition
July 2, 2009
Pegasus Biologics, Inc.

More Recent News About Synovis Life Technologies, Inc.

  • Synovis Life Technologies to Present at Oppenheimer 20th Annual Healthcare Conference November 3 

    HASH(0x2a966b3100) Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) ST. PAUL, Minn. -- Synovis Life Technologies, Inc....

    Business Wire, 10/29/09 · More from publication

Would you like to leave a comment about Synovis Life Technologies, Inc. (SYNO)?

Besides Synovis Life Technologies, Inc. there is more great information available at Realpennies.com